Isolated from other cells in a laboratory dish, tumour cells won't reveal their actual nature. Rice University researchers created an improved tumour model that houses osteosarcoma cells alongside immune cells known as macrophages inside a three-dimensional framework designed to simulate bon
Personalization of cancer treatments has long been a goal--finding the right drugs that work for a patient's specific tumour based on specific genetic and molecular patterns. Many of these targeted therapies are highly effective, but they are not available for all cancers, including NSCLCs w
Researchers at the Perelman School of Medicine at the University of Pennsylvania have been working on a preclinical study that focuses on a novel strategy that uses a "one-two punch" to assist T cells in attacking solid tumours. The results, which were reported in the Proceedings of the Nati
A new weapon in the arsenal of cancer cells' treatment resistance, according to a study conducted by the Garvan Institute of Medical Research, is the ability for them to respond randomly to chemotherapy.
An advanced imaging method is showing promise as a way to improve the diagnosis of prostate cancer by giving clinicians a clearer view of suspected tumours during biopsy.
An advanced imaging approach is showing promise in improving prostate cancer detection by providing doctors with a clearer image of suspected tumours during the biopsy.
According to recent research led by the Garvan Institute of Medical Research, cancer cells have an inbuilt randomness in their capacity to respond to chemotherapy, which is another weapon in their treatment resistance toolbox.
Cherry had "no route to treatment until after the birth," of a child while carrying her second baby in 2022, the singer recalled in a press release on Tuesday, reported Page Six, a US-based media company.
Experiments on mice and human cells reveal that the number of specialised immune cells ready to combat skin cancer increased when a novel therapy prevented their egress from melanoma tumours.
Researchers from UCL Cancer Center have offered essential molecular insights into how an injury may lead to the formation of glioma, a relatively rare but typically aggressive kind of brain tumour.